Mark J. Bamford

1.6k total citations
41 papers, 1.2k citations indexed

About

Mark J. Bamford is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Mark J. Bamford has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Organic Chemistry and 6 papers in Epidemiology. Recurrent topics in Mark J. Bamford's work include Carbohydrate Chemistry and Synthesis (7 papers), Chemical Synthesis and Analysis (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mark J. Bamford is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), Chemical Synthesis and Analysis (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mark J. Bamford collaborates with scholars based in United Kingdom, Germany and United States. Mark J. Bamford's co-authors include Elaine Irving, Richard Storer, Richard Walker, Paul L. Coe, Mark G. Moloney, Duncan S. Holmes, Robert J. Watson, Jonathan M. J. Williams, Paweł Pluciński and David C. Humber and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Mark J. Bamford

41 papers receiving 1.1k citations

Peers

Mark J. Bamford
Nigel J. Liverton United States
Steven H. Olson United States
Stefania Girotto Italy
Robert J. DeVita United States
Erich L. Grimm Canada
Hiroyuki Miyachi Japan
Shifeng Pan China
James B. Summers United States
Allan R. Moorman Italy
Qi Sun China
Nigel J. Liverton United States
Mark J. Bamford
Citations per year, relative to Mark J. Bamford Mark J. Bamford (= 1×) peers Nigel J. Liverton

Countries citing papers authored by Mark J. Bamford

Since Specialization
Citations

This map shows the geographic impact of Mark J. Bamford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Bamford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Bamford more than expected).

Fields of papers citing papers by Mark J. Bamford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Bamford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Bamford. The network helps show where Mark J. Bamford may publish in the future.

Co-authorship network of co-authors of Mark J. Bamford

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Bamford. A scholar is included among the top collaborators of Mark J. Bamford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Bamford. Mark J. Bamford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richards, Duncan, Mark J. Bamford, Lia Liefaard, et al.. (2019). Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro‐drug of miridesap. British Journal of Pharmacology. 177(8). 1853–1864. 3 indexed citations
2.
McBride, Andrew, Anna M. Hoy, Mark J. Bamford, et al.. (2017). In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis. Scientific Reports. 7(1). 10806–10806. 22 indexed citations
3.
Saidi, Ourida, Mark J. Bamford, A. John Blacker, et al.. (2010). Iridium-catalyzed formylation of amines with paraformaldehyde. Tetrahedron Letters. 51(44). 5804–5806. 60 indexed citations
4.
Garton, Neil, et al.. (2009). Discovery of biaryl inhibitors of H+/K+ ATPase. Bioorganic & Medicinal Chemistry Letters. 20(3). 1049–1054. 8 indexed citations
5.
Bamford, Mark J.. (2009). 3 H+/K+ ATPase Inhibitors in the Treatment of Acid-Related Disorders. Progress in medicinal chemistry. 47. 75–162. 18 indexed citations
6.
Bamford, Mark J., Emmanuel H. Demont, Richard L. Elliott, et al.. (2009). Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs). Bioorganic & Medicinal Chemistry Letters. 19(13). 3602–3606. 12 indexed citations
7.
Panchal, Terry, Mark J. Bamford, Emmanuel H. Demont, et al.. (2009). Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs). Bioorganic & Medicinal Chemistry Letters. 19(23). 6813–6817. 10 indexed citations
8.
Angell, Richard, Paul Bamborough, Mark J. Bamford, et al.. (2008). Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. Bioorganic & Medicinal Chemistry Letters. 18(15). 4433–4437. 52 indexed citations
9.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3402–3406. 30 indexed citations
10.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3407–3411. 19 indexed citations
11.
Bamford, Mark J., et al.. (2000). Therapeutic Applications of Apoptosis Research. Experimental Cell Research. 256(1). 1–11. 34 indexed citations
12.
Moloney, Mark G., et al.. (2000). Pyrrolidinones derived from (S )-pyroglutamic acid. Part 1. Conformationally constrained glutamate. Journal of the Chemical Society Perkin Transactions 1. 2783–2792. 27 indexed citations
13.
Moloney, Mark G., et al.. (1997). Functionalised pyrrolidinones derived from (S)-pyroglutamic acid by cycloaddition reactions. Tetrahedron. 53(34). 11731–11744. 28 indexed citations
14.
Prodger, Jeremy C., Mark J. Bamford, Michael I. Bird, et al.. (1996). Mimics of the sialyl Lewis X tetrasaccharide. Replacement of the N-Acetylglucosamine sugar with simple C2-symmetric 1,2-diols. Bioorganic & Medicinal Chemistry. 4(6). 793–801. 17 indexed citations
15.
16.
17.
Procopiou, Panayiotis A., Mark J. Bamford, Brian Dymock, et al.. (1994). The Squalestatins: Novel Inhibitors of Squalene Synthase. Enzyme Inhibitory Activities and in vivo Evaluation of C1-Modified Analogs. Journal of Medicinal Chemistry. 37(20). 3274–3281. 16 indexed citations
18.
Humber, David C., Mark J. Bamford, Richard C. Bethell, et al.. (1993). A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships. Journal of Medicinal Chemistry. 36(21). 3120–3128. 15 indexed citations
19.
Bamford, Mark J., Paul L. Coe, & Richard Walker. (1990). Synthesis and antiviral activity of some 3'-C-difluoromethyl- and 3'-deoxy-3'-C-fluoromethyl nucleosides. Journal of Medicinal Chemistry. 33(9). 2488–2494. 19 indexed citations
20.
Bamford, Mark J., Paul L. Coe, & Richard Walker. (1990). Synthesis and antiviral activity of 3'-deoxy-3'-C-hydroxymethyl nucleosides. Journal of Medicinal Chemistry. 33(9). 2494–2501. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nigel J. Liverton Breakdown of academic impact, for papers by Steven H. Olson Breakdown of academic impact, for papers by Stefania Girotto Breakdown of academic impact, for papers by Robert J. DeVita Breakdown of academic impact, for papers by Erich L. Grimm Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Shifeng Pan Breakdown of academic impact, for papers by James B. Summers Breakdown of academic impact, for papers by Allan R. Moorman Breakdown of academic impact, for papers by Qi Sun
Rankless by CCL
2026